This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovator Giuseppe De Franza: Advancing Digestive Health
Introduction: Giuseppe De Franza, an accomplished inventor based in Pessano con Bornago, Italy, has made significant contributions to the field of digestive health through his innovative pharmaceutical formulations. With two patents to his name, De Franza focuses on improving the quality of life for individuals struggling with digestive enzyme deficiencies.
Latest Patents: De Franza's latest work includes a groundbreaking patent for a stable low digestive enzyme content formulation. This invention is designed to provide a pharmaceutical composition or dosage form that maintains a stable, diluted content of at least one digestive enzyme combined with a suitable carrier. The innovation outlines a method for preparing this composition and aims to treat and prevent disorders related to digestive enzyme deficiencies, offering a solution to patients in need.
Career Highlights: Currently, Giuseppe De Franza is associated with Société des Produits Nestlé S.A., a renowned global company dedicated to nutrition, health, and wellness. His role at Nestlé has allowed him to further his research and application of innovative health solutions, particularly in the area of digestive health.
Collaborations: Throughout his career, De Franza has collaborated with talented professionals, including Giovanni Ortenzi and Danilo Clementi. These partnerships foster a collaborative environment, driving research and development efforts in pharmaceutical formulations.
Conclusion: Giuseppe De Franza stands out as a visionary inventor whose work impacts digestive health positively. With his innovative patents and dedication to research, he continues to contribute to advancements in healthcare, enhancing the lives of those affected by digestive enzyme deficiencies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
